SC
AGN.PRA

Scotia Capital’s Allergan plc AGN.PRA Stock Holding History

Scotia Capital’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,000
Closed -$1.64M – 913
2016
Q3 		$1.64M Buy
2,000
+1,000
+100% +$864K 0.03% 336
2016
Q2 		$831K Buy
1,000
+250
+33% +$209K 0.02% 420
2016
Q1 		$688K Buy
750
+550
+275% +$526K 0.02% 419
2015
Q4 		$205K Sell
200
-2,800
-93% -$2.81M ﹤0.01% 734
2015
Q3 		$2.84M Buy
3,000
+1,500
+100% +$1.56M 0.06% 206
2015
Q2 		$1.57M Buy
+1,500
New +$1.57M 0.03% 315

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.94B AUM 9.49% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Scotia Capital's AGN.PRA Position: Q4 2016 in Review

Scotia Capital sold out of Allergan plc (AGN.PRA) in Q4 2016, closing a stake of 2,000 shares — an estimated $1.64M sold.

Scotia Capital first reported a position in AGN.PRA in Q2 2015 and held it in 6 quarters. The position peaked at $2.84M in Q3 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

  • Scotia Capital reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Scotia Capital sold 2,000 Allergan plc shares in Q4 2016, an estimated $1.64M.
  • Scotia Capital first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
  • Scotia Capital's Allergan plc position peaked at $2.84M in Q3 2015.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Scotia Capital's 13F filing for Q4 2016, filed 14 Feb 2017.